The American Heart Journal has now published my letter criticizing a safety trial of the HDL-cholesterol-boosting drug anacetrapib for not measuring the drug's effect on vitamin E transport.
Index for Pubmed
Full Text of Letter — Effect of Cholesteryl Ester Transfer Protein Inhibitor on Vitamin E Transport Should Be Studied
Authors' Response
Brilliant letter, and could be the basis for a publishable article in and of itself! Many thanks for this analysis and for getting the word out.
ReplyDeleteThanks William!
ReplyDeleteI checked the author's response: a meta-analysis was cited as showing no CV benefit of 'vitamin E'. Of course, no mention is made of what components of 'vitamin E' were used. I'd bet it was d-alpha tocopherol, maybe even some dl-. Yikes.
ReplyDeleteI have read news regarding vitamin E and other beneficial supplements for the body.I agree with one of the review that I checked the author's response: a meta-analysis was cited as showing no CV benefit of 'vitamin E'. Of course, no mention is made of what components of 'vitamin E' were used.The Vitamin E plays vital role in the formation of the human body.
ReplyDeletewomens health